Moxalactam pharmacokinetics during hemodialysis
Open Access
- 1 April 1981
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 19 (4) , 575-577
- https://doi.org/10.1128/aac.19.4.575
Abstract
To establish dosage recommendations, moxalactam elimination kinetics were studied in six anephric patients during hemodialysis and in four anephric patients during the interdialytic period. After a single 1-g intravenous bolus injection, moxalactam elimination half-life was 18.0 plus or minus 0.6 h with a volume of distribution of 20.2 plus or minus 3.6 liters and a plasma clearance of 12.8 plus or minus 2.0 ml/min in four nondialyzed patients. Moxalactam elimination half-life was decreased to 2.7 plus or minus 0.2 h during hemodialysis in six patients. After 4 h, 48.5% of the dose was recovered in the dialysate. The maintenance dose of moxalactam should be decreased to 15% of a normal dose in patients with creatinine clearances less than 10 ml/min, and 50% of a loading dose should be given after hemodialysis.This publication has 6 references indexed in Scilit:
- Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycinAntimicrobial Agents and Chemotherapy, 1980
- Pharmacology of a New 1-Oxa-β-lactam (LY127935) in Normal VolunteersAntimicrobial Agents and Chemotherapy, 1980
- Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1980
- Clearance calculations in hemodialysis: Application to blood, plasma, and dialysate measurements for ethambutolJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Artificial kidneys and clearance calculationsClinical Pharmacology & Therapeutics, 1976
- Clinical PharmacokineticsNew England Journal of Medicine, 1975